Aquatic Capital Management LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1803916 CHICAGO, IL

Position in ARWR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,030,232

-$344,569 QoQ

Shares Held

80,227

-0.9% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Aquatic Capital Management LLC holds $123,092,373 across 91 Biotechnology names. ARWR ranks #5 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	147,379	$11,066,689
2	ALNY	Alnylam Pharmaceuticals, Inc.	31,061	$10,277,153
3	EXEL	Exelixis, Inc.	194,571	$8,345,150
4	RPRX	Royalty Pharma plc	127,227	$6,103,079
5	ARWR	Arrowhead Pharmaceuticals, Inc. This page	80,227	$5,030,232
6	CYTK	Cytokinetics Inc	72,478	$4,777,024
7	XENE	Xenon Pharmaceuticals Inc.	79,199	$4,605,421
8	NKTR	Nektar Therapeutics	57,014	$4,102,157

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,030,232	80,227	-0.9%	Shares	Sole	2026-05-15
2025-12-31	$5,374,801	80,958	+215.4%	Shares	Sole	2026-02-17
2025-09-30	$885,392	25,671	-72.7%	Shares	Sole	2025-11-14
2025-06-30	$1,483,288	93,879	-7.4%	Shares	Sole	2025-08-14
2025-03-31	$1,290,956	101,331	-40.2%	Shares	Sole	2025-05-15
2024-12-31	$3,184,607	169,394	+80.9%	Shares	Sole	2025-02-14
2024-09-30	$1,813,380	93,618	+963.8%	Shares	Sole	2024-11-14
2023-03-31	$223,520	8,800	-3.3%	Shares	Sole	2023-05-15
2022-09-30	$300,755	9,100	+1037.5%	Shares	Sole	2022-11-14
2022-03-31	$36,792	800	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.